# A Phase 2 Clinical Study of CU-20401

> **NCT06194188** · PHASE2 · COMPLETED · sponsor: **Cutia Therapeutics（Wuxi）Co.,Ltd** · enrollment: 108 (actual)

## Conditions studied

- Efficacy and Safety

## Interventions

- **DRUG:** Subcutaneous injection of CU-20401

## Key facts

- **NCT ID:** NCT06194188
- **Lead sponsor:** Cutia Therapeutics（Wuxi）Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-20
- **Primary completion:** 2024-09-02
- **Final completion:** 2024-09-02
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06194188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06194188, "A Phase 2 Clinical Study of CU-20401". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06194188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*